Using the Future Elderly Model, researchers evaluated the potential health benefits from innovation in heart failure treatment.
Researchers evaluated the economic impact of older adults and the value of their unpaid, productive activities and financial gifts to family.
The researchers reviewed 112 experimental or quasi-experimental studies on the effects of health insurance prior to people becoming eligible for Medicare on a broad set of outcomes.
This study estimated the future prevalence of diabetes among Mexico’s older adults to assess the current and future health and economic burden of diabetes.
Patricia St. Clair and her colleagues assess prevalence of diabetes and heart attack in the US elderly population across the most well used data sources for estimation.
Heckman and his colleagues estimate the internal rate of return is 13.7 percent for the high quality early childhood education program analyzed. The associated benefit/cost ratio is 7.3.
The Future Americans Model (FAM) was adapted to estimate benefits from an influential early childhood program.
Growing gap in life expectancy by income increases gap in lifetime retirement benefits including Medicare by $130,000
Many people who use statins to fight heart disease seem to be on a slower track for developing Alzheimer’s compared to the rest of the population. Yet multiple hurdles stand in the way for this sort of study.
High-cost drugs can generate even higher societal value when they combat serious disease, which should be accounted for in financing methods and pricing models to encourage medical innovation.